GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $2,048,000 | -16.7% | 48,585 | -23.9% | 0.29% | -23.6% |
Q4 2016 | $2,459,000 | -0.6% | 63,850 | +11.3% | 0.38% | +2.7% |
Q3 2016 | $2,475,000 | -5.0% | 57,380 | -4.5% | 0.37% | -15.6% |
Q2 2016 | $2,605,000 | -3.6% | 60,107 | -9.8% | 0.44% | -4.6% |
Q1 2016 | $2,703,000 | +480.0% | 66,650 | +477.1% | 0.46% | +524.7% |
Q4 2015 | $466,000 | +15.3% | 11,549 | +10.0% | 0.07% | +10.6% |
Q3 2015 | $404,000 | – | 10,500 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |